Private equity firm Carlyle Group is currently in exclusive negotiations to acquire Baxter International’s kidney care spinoff, Vantive, for more than $4
Private equity firm Carlyle Group is currently in exclusive negotiations to acquire Baxter International’s kidney care spinoff, Vantive, for more than $4